Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Integer Holdings Corporation stock logo
ITGR
Integer
$126.35
+0.0%		$117.59
$62.00
▼
$126.79
$4.29B0.62718,478 shs830,919 shs
LivaNova PLC stock logo
LIVN
LivaNova
$78.01
+0.3%		$79.93
$48.82
▼
$85.76
$4.29B0.87560,069 shs1.38 million shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$53.87
+6.4%		$42.85
$12.56
▼
$58.90
$3.58B1.63622,669 shs867,490 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$19.30
-0.9%		$20.16
$16.67
▼
$39.99
$1.12B0.911.07 million shs1.49 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Integer Holdings Corporation stock logo
ITGR
Integer
-0.04%+0.22%+0.84%+38.92%+23.05%
LivaNova PLC stock logo
LIVN
LivaNova
+0.28%-0.22%-3.50%-0.62%+43.06%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
+6.44%+1.43%+14.57%+110.43%+231.10%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-0.87%-5.30%-11.91%-11.14%-48.23%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Integer Holdings Corporation stock logo
ITGR
Integer
$126.35
+0.0%		$117.59
$62.00
▼
$126.79
$4.29B0.62718,478 shs830,919 shs
LivaNova PLC stock logo
LIVN
LivaNova
$78.01
+0.3%		$79.93
$48.82
▼
$85.76
$4.29B0.87560,069 shs1.38 million shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$53.87
+6.4%		$42.85
$12.56
▼
$58.90
$3.58B1.63622,669 shs867,490 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$19.30
-0.9%		$20.16
$16.67
▼
$39.99
$1.12B0.911.07 million shs1.49 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Integer Holdings Corporation stock logo
ITGR
Integer
-0.04%+0.22%+0.84%+38.92%+23.05%
LivaNova PLC stock logo
LIVN
LivaNova
+0.28%-0.22%-3.50%-0.62%+43.06%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
+6.44%+1.43%+14.57%+110.43%+231.10%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-0.87%-5.30%-11.91%-11.14%-48.23%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Integer Holdings Corporation stock logo
ITGR
Integer
2.07
Hold$109.86-13.05% Downside
LivaNova PLC stock logo
LIVN
LivaNova
2.55
Moderate Buy$84.137.84% Upside
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
2.83
Moderate Buy$45.25-16.00% Downside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.20
Hold$25.0930.00% Upside

Current Analyst Ratings Breakdown

Latest PRCT, LIVN, ITGR, and PLSE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/14/2026
Integer Holdings Corporation stock logo
ITGR
Integer
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/9/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Perform
9/9/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Freedom Capmkts logo
Freedom Capmkts
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
9/2/2026
LivaNova PLC stock logo
LIVN
LivaNova
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$87.00 ➝ $90.00
8/19/2026
LivaNova PLC stock logo
LIVN
LivaNova
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/18/2026
LivaNova PLC stock logo
LIVN
LivaNova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
8/17/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$58.00
8/13/2026
Integer Holdings Corporation stock logo
ITGR
Integer
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
8/10/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$45.00
8/10/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$32.00 ➝ $43.00
8/5/2026
LivaNova PLC stock logo
LIVN
LivaNova
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$85.00
(Data available from 9/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Integer Holdings Corporation stock logo
ITGR
Integer
$1.85B2.32$10.36 per share12.19$49.85 per share2.53
LivaNova PLC stock logo
LIVN
LivaNova
$1.39B3.10$4.85 per share16.08$21.98 per share3.55
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$350K10,897.13N/AN/A$1.19 per share45.27
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$308.05M3.59N/AN/A$6.55 per share2.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$3.6634.5218.832.406.97%12.79%6.48%10/22/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.3823.0818.84N/A12.82%16.35%7.76%11/4/2026 (Estimated)
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$72.78M-$1.18N/AN/AN/A-6,755.78%-94.42%-79.96%11/4/2026 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$95.57M-$1.94N/AN/AN/A-32.53%-30.62%-22.10%11/3/2026 (Estimated)

Latest PRCT, LIVN, ITGR, and PLSE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.09$1.26+$0.17$1.93$380.50 million$390.59 million
8/6/2026Q2 2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$0.2933-$0.36-$0.0667-$0.36$0.53 million$0.43 million
8/4/2026Q2 2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.4619-$0.47-$0.0081-$0.47$92.77 million$94.50 million
8/3/2026Q2 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.38$1.60+$0.22$0.69$451.07 million$464.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Integer Holdings Corporation stock logo
ITGR
Integer
0.75
3.73
2.41
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.45
1.21
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/A
9.63
9.61
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.15
6.55
5.35

Institutional Ownership

CompanyInstitutional Ownership
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
76.95%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%

Insider Ownership

CompanyInsider Ownership
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
74.00%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
4.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00034.00 million33.62 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.90 millionOptionable
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
11670.80 million18.41 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
88857.27 million54.98 millionOptionable

Recent News About These Companies

PROCEPT DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action – PRCT
September 18 at 10:59 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/19/3364996/673/en/procept-deadline-rosen-a-ranked-and-leading-law-firm-encourages-procept-biorobotics-corporation-investors-to-secure-counsel-before-important-september-22-deadline-in-securities-cla.html
PROCEPT 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
September 18 at 7:26 PM  |  businesswire.comhttps://www.businesswire.com/news/home/20260918699212/en/procept-96-hour-deadline-alert-kahn-swick-foti-llc-reminds-investors-with-losses-in-excess-of-100000-of-deadline-in-class-action-lawsuit-against-procept-biorobotics-corporation---prct/
Kaplan Fox Alerts Investors of PROCEPT BioRobotics Corporation (PRCT) to a Federal Securities Class Action - Deadline is September 22, 2026
September 18 at 3:15 PM  |  newsfilecorp.comN
PRCT 4-DAY DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit
September 18 at 2:47 PM  |  newsfilecorp.comN
TUESDAY PRCT INVESTOR DEADLINE: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit
September 18 at 11:30 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tuesday-prct-investor-deadline-procept-biorobotics-corporation-investors-with-substantial-losses-have-opportunity-to-lead-the-procept-class-action-lawsuit-302882764.html
Bragar Eagel & Squire, P.C Urges PROCEPT BioRobotics Corporation Investors to Contact the Firm Seeking Lead Plaintiff Role Before September 22nd
September 18 at 11:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/18/3364803/0/en/bragar-eagel-squire-p-c-urges-procept-biorobotics-corporation-investors-to-contact-the-firm-seeking-lead-plaintiff-role-before-september-22nd.html
Kaplan Fox Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to a Securities Fraud Lawsuit – Lead Plaintiff Deadline is September 22, 2026
September 18 at 10:18 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/18/3364767/1020/en/kaplan-fox-alerts-procept-biorobotics-corporation-nasdaq-prct-investors-to-a-securities-fraud-lawsuit-lead-plaintiff-deadline-is-september-22-2026.html
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (PRCT) Investors With Substantial Losses to Contact the Firm Before September 22, 2026
September 17 at 3:00 PM  |  newsfilecorp.comN
PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline
September 17 at 12:22 PM  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/09/17/10447818.htm
PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
September 17 at 11:53 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/17/3364220/35454/en/procept-biorobotics-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-procept-biorobotics-.html
SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026 - PRCT
September 17 at 10:07 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/suewallst-reminds-procept-biorobotics-corporation-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-22-2026---prct-302881749.html
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law
September 17 at 10:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/17/3364139/0/en/prct-investors-have-opportunity-to-lead-procept-biorobotics-corporation-securities-fraud-lawsuit-with-sbs-law.html
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines - PRCT
September 17 at 10:00 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-procept-biorobotics-corporation-of-class-action-lawsuit-and-upcoming-deadlines--prct-302881560.html
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against PROCEPT BioRobotics Corporation (PRCT)
September 17 at 8:17 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/17/3363950/0/en/shareholder-alert-bernstein-liebhard-llp-announces-a-securities-fraud-class-action-lawsuit-has-been-filed-against-procept-biorobotics-corporation-prct.html
PRCT 6-DAY DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit
September 16 at 5:00 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/16/3363573/32716/en/prct-6-day-deadline-alert-procept-biorobotics-corporation-investors-alerted-to-september-22-2026-lead-plaintiff-deadline-in-class-action-lawsuit.html
Kaplan Fox Reminds PROCEPT BioRobotics Corporation (PRCT) Investors That They Have Until September 22, 2026 to Move for Lead Plaintiff
September 16 at 1:00 PM  |  newsfilecorp.comN
PRCT Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in PROCEPT BIOROBOTICS CORPORATION Securities Lawsuit - Contact Levi & Korsinsky
September 16 at 10:09 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/prct-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-procept-biorobotics-corporation-securities-lawsuit---contact-levi--korsinsky-302880229.html
Kaplan Fox Advises Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) of an Upcoming Securities Class Action Deadline on September 22, 2026
September 16 at 7:45 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/16/3363078/1020/en/kaplan-fox-advises-investors-of-procept-biorobotics-corporation-nasdaq-prct-of-an-upcoming-securities-class-action-deadline-on-september-22-2026.html
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
September 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/16/3362815/6713/en/procept-biorobotics-corporation-securities-fraud-class-action-result-of-undisclosed-inventory-issues-and-approximately-18-stock-decline-investors-may-contact-lewis-kahn-esq-at-kahn.html
PROCEPT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action – PRCT
September 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/16/3362797/673/en/procept-deadline-rosen-nationally-regarded-investor-counsel-encourages-procept-biorobotics-corporation-investors-to-secure-counsel-before-important-september-22-deadline-in-securit.html
Amundi Has $2.27 Million Position in PROCEPT BioRobotics Corporation $PRCT
September 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-amundi-has-227-million-position-in-procept-biorobotics-corporation-prct-2026-09-14/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Integer stock logo

Integer NYSE:ITGR

$126.35 +0.02 (+0.01%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$126.28 -0.07 (-0.05%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$78.01 +0.22 (+0.28%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$78.00 -0.02 (-0.02%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Pulse Biosciences stock logo

Pulse Biosciences NASDAQ:PLSE

$53.87 +3.26 (+6.44%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$53.89 +0.02 (+0.04%)
As of 09/18/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$19.30 -0.17 (-0.87%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$19.30 +0.00 (+0.03%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas